Citadel Advisors - INTEGRA LIFESCIENCES HLDGS C ownership

INTEGRA LIFESCIENCES HLDGS C's ticker is IART and the CUSIP is 457985208. A total of 273 filers reported holding INTEGRA LIFESCIENCES HLDGS C in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of INTEGRA LIFESCIENCES HLDGS C
ValueSharesWeighting
Q2 2023$16,672,498
+135.8%
405,361
+229.1%
0.00%
+200.0%
Q1 2023$7,070,328
-37.5%
123,155
-38.9%
0.00%
-50.0%
Q4 2022$11,307,132
-5.8%
201,661
-28.8%
0.00%
-33.3%
Q3 2022$12,005,000
-14.2%
283,409
+9.4%
0.00%
-25.0%
Q2 2022$13,999,000
+6.4%
259,104
+26.6%
0.00%
+33.3%
Q1 2022$13,153,000
+269.8%
204,675
+285.5%
0.00%
+200.0%
Q4 2021$3,557,000
+532.9%
53,099
+546.8%
0.00%
Q3 2021$562,000
+64.8%
8,209
+64.2%
0.00%
Q2 2021$341,000
-0.3%
5,000
+1.1%
0.00%
Q1 2021$342,000
-90.4%
4,948
-91.0%
0.00%
-100.0%
Q4 2020$3,560,000
+73.0%
54,822
+25.8%
0.00%
Q3 2020$2,058,000
-79.4%
43,591
-79.5%
0.00%
-100.0%
Q2 2020$10,005,000
-3.9%
212,906
-8.7%
0.00%
-40.0%
Q1 2020$10,415,000
+66.0%
233,157
+116.5%
0.01%
+66.7%
Q4 2019$6,275,000
-41.5%
107,674
-39.7%
0.00%
-40.0%
Q3 2019$10,723,000
-7.6%
178,505
-14.1%
0.01%0.0%
Q2 2019$11,607,000
+51.9%
207,836
+51.6%
0.01%
+66.7%
Q1 2019$7,639,000
-38.9%
137,085
-50.6%
0.00%
-57.1%
Q4 2018$12,506,000
+113.3%
277,298
+211.5%
0.01%
+250.0%
Q3 2018$5,863,000
+503.2%
89,006
+490.0%
0.00%
Q2 2018$972,000
+162.0%
15,087
+125.2%
0.00%
Q1 2018$371,000
-98.4%
6,700
-98.8%
0.00%
-100.0%
Q1 2017$22,716,000
+2597.9%
539,185
+5395.2%
0.02%
+2000.0%
Q4 2016$842,000
+277.6%
9,812
+263.4%
0.00%
Q3 2016$223,000
-98.6%
2,700
-98.9%
0.00%
-100.0%
Q1 2016$15,900,000
+30.4%
236,039
+31.2%
0.02%
+53.8%
Q4 2015$12,195,000
+42.3%
179,920
+25.1%
0.01%
+62.5%
Q3 2015$8,567,000
+17383.7%
143,864
+17860.5%
0.01%
Q1 2015$49,000
-95.4%
801
-95.9%
0.00%
-100.0%
Q4 2014$1,063,000
-20.8%
19,599
-27.5%
0.00%0.0%
Q3 2014$1,342,000
-1.8%
27,038
-6.9%
0.00%
-50.0%
Q2 2014$1,367,000
+41.7%
29,042
+38.4%
0.00%
+100.0%
Q1 2014$965,000
-73.5%
20,982
-72.5%
0.00%
-80.0%
Q4 2013$3,640,000
-11.1%
76,278
-25.0%
0.01%
-16.7%
Q3 2013$4,095,000
+178.6%
101,743
+153.5%
0.01%
+100.0%
Q2 2013$1,470,00040,1320.00%
Other shareholders
INTEGRA LIFESCIENCES HLDGS C shareholders Q1 2022
NameSharesValueWeighting ↓
Champlain Investment Partners, LLC 5,473,820$305,001,0002.66%
FALCON POINT CAPITAL, LLC 80,729$4,498,0002.45%
Tributary Capital Management, LLC 508,838$28,352,0002.06%
Broadfin Capital, LLC 141,572$7,888,0001.63%
MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income 182,585$10,174,0001.57%
Sapience Investments, LLC 132,810$7,400,0000.98%
VAUGHAN NELSON INVESTMENT MANAGEMENT, L.P. 1,110,177$61,860,0000.83%
Bellevue Group AG 222,350$12,389,0000.68%
Capital International Sarl 74,325$4,141,0000.52%
Hood River Capital Management LLC 180,772$10,073,0000.51%
View complete list of INTEGRA LIFESCIENCES HLDGS C shareholders